Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin with Gemcitabine and Cisplatin in Advanced Bladder Cancer
NCT01126749Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2010
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of eribulin in bladder cancer, sponsored by Eisai Co., Ltd.. Started Apr 2010; status: terminated.
02
Drugs
eribulin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01126749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01126749.